NextCure Inc.

NASDAQ: NXTC · Real-Time Price · USD
5.17
0.02 (0.43%)
At close: Aug 15, 2025, 3:47 PM
5.00
-3.38%
After-hours: Aug 15, 2025, 06:39 PM EDT

NextCure Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 3.28M n/a n/a n/a 6.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
633K 654K n/a 700K 701K 940K 824K 946K 1.09M 1.11M n/a 1.02M n/a 2.1M 2.1M 2.1M 1.89M 1.1M
Gross Profit
-633K -654K 1.64M -700K -701K -940K 5.46M -946K -1.09M -1.11M n/a -1.02M n/a -2.1M -2.1M -2.1M -1.89M -1.1M
Operating Income
-27.29M -11.62M -12.46M -12.49M -16.49M -15.76M -15.79M -15.62M -19.16M -17.07M -17.77M -19.24M -18.13M -20.77M -17.07M -18.51M -17.95M -17.23M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 1.32K 1.3K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-26.81M -10.98M -11.6M -11.54M -15.4M -17.11M -14.47M -14.3M -17.86M -16.1M -17.3M -18.91M -17.92M -20.6M -16.94M -17.93M -17.99M -16.53M
Net Income
-26.81M -10.98M -11.6M -11.54M -15.4M -17.11M -14.47M -14.3M -17.86M -15.12M -17.3M -18.58M -17.71M -20.43M -16.94M -17.93M -17.99M -16.53M
Selling & General & Admin
3.2M 3.73M 3.55M 3.73M 3.38M 4.36M 3.14M 4.61M 5.71M 5.42M 4.95M 5.71M 5.3M 5.75M 4.81M 4.91M 6.01M 4.85M
Research & Development
24.09M 7.9M 8.9M 8.77M 12.42M 11.4M 11.83M 11.01M 13.45M 11.65M 12.82M 13.53M 12.82M 15.02M 12.26M 13.6M 11.95M 12.39M
Other Expenses
n/a n/a n/a n/a n/a 2.54M 824K n/a 1.3M 975K n/a 328K n/a 169K 132K 578K -35K 701K
Operating Expenses
27.29M 11.62M 12.46M 12.49M 15.79M 18.3M 15.79M 15.62M 19.16M 17.07M 17.77M 19.24M 18.13M 20.77M 17.07M 18.51M 17.95M 17.23M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -701K n/a -824K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
27.29M 11.62M 12.46M 12.49M 16.49M 15.76M 15.79M 15.62M 19.16M 17.07M 17.77M 19.24M 18.13M 20.77M 17.07M 18.51M 17.95M 17.23M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -975K n/a -328K -207K -169K n/a n/a n/a n/a
Shares Outstanding (Basic)
2.37M 2.33M 2.33M 2.33M 2.33M 2.33M 2.33M 2.32M 2.32M 2.31M 2.31M 2.31M 2.31M 2.31M 2.3M 2.3M 2.3M 2.3M
Shares Outstanding (Diluted)
2.37M 2.33M 2.33M 2.33M 2.33M 2.33M 2.33M 2.32M 2.32M 2.31M 2.31M 2.31M 2.31M 2.31M 2.3M 2.3M 2.3M 2.3M
EPS (Basic)
-11.29 -4.7 -4.97 -4.95 -6.61 -7.36 -6.22 -6.16 -7.7 -6.95 -7.47 -8.18 -7.75 -8.92 -7.35 -7.79 -7.82 -7.19
EPS (Diluted)
-11.29 -4.7 -4.97 -4.95 -6.61 -7.36 -6.22 -6.16 -7.7 -6.95 -7.47 -8.18 -7.75 -8.92 -7.35 -7.79 -7.82 -7.19
EBITDA
-27.29M -10.97M -11.78M -11.79M -15.79M -14.97M -14.97M -14.67M -18.2M -16.11M -16.76M -18.22M -17.09M -19.71M -14.84M -16.77M -17.66M -16.13M
EBIT
-26.81M -11.62M -12.46M -12.49M -16.49M -15.76M -15.79M -15.62M -19.16M -17.07M -17.77M -19.24M -18.13M -20.77M -17.07M -18.51M -17.95M -17.23M
Depreciation & Amortization
n/a 654K 674K 700K 701K 790K 824K 946K 1.09M 1.11M 1.01M 1.02M 1.04M 2.1M 2.1M 2.1M 1.89M 1.1M